- Tytuł:
- 156P A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in advanced Epstein-Barr virus positive (EBV+) solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (RM-NPC)
- Autorzy:
- Źródło:
- In Immuno-Oncology and Technology December 2022 16 Supplement 1
Czasopismo naukowe